Skip to Content

WPI 338 (Diclofenac sodium delayed release 50 mg)

Pill imprint WPI 338 has been identified as Diclofenac sodium delayed release 50 mg.

Diclofenac is used in the treatment of back pain; pain; ankylosing spondylitis; frozen shoulder; muscle pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 50 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Diclofenac sodium delayed release 50 mg WPI 338
Diclofenac sodium delayed release 50 mg WPI 338
Diclofenac sodium delayed release
WPI 338
50 mg
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Watson Pharmaceuticals
National Drug Code (NDC):

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.